Conference
A phase 2, single agent study of Cl-1033 administered at two doses in ovarian cancer patients who failed platinum therapy.
Authors
Campos SM; Seiden MV; Oza A; Plante M; Potkul R; Hamid O; Lenehan P; Kaldjian E; Jordan C; Hirte H
Volume
22
Pagination
pp. 462S-462S
Publisher
AMER SOC CLINICAL ONCOLOGY
Publication Date
July 15, 2004
Name of conference
40th Annual Meeting of the American-Society-of-Clinical-Oncology
Conference place
LA, New Orleans
Conference start date
June 5, 2004
Conference end date
June 8, 2004
Conference proceedings
JOURNAL OF CLINICAL ONCOLOGY
Issue
14
ISSN
0732-183X